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Plasmid pCIS7, containing 11.5 kilobases (kb) of Bacillus subtilis DNA, was isolated from a Tn917
transposon insertion in tetracycline-sensitive B. subtilis KS162. When integrated into the chromosome of B.
subtilis 168, this plasmid conferred tetracycline resistance upon reiteration of the plasmid DNA sequences in the
chromosome. Deletions and subclones of pCIS7 were constructed and introduced into an Escherichia coli in
vitro transcription-translation system. A 72-kilodalton protein was localized to a 3.1-kb PstI-EcoRI fragment
of the plasmid. Amplification of the 3.1-kb PstI-EcoRI fragment was required for expression of tetracycline
resistance in B. subtilis 168. By hybridization to previously characterized clones, the 11.5-kb fragment was
localized to the origin region of the chromosome. Through contour-clamped homogeneous electric field
electrophoresis, this cluster of clones was shown to reside on a 200-kb NotI fragment bridging Sfi1 fragments
of 150 and 250 kb and was oriented with respect to the purA and guaA loci, developing an accurate physical
map of the region surrounding the origin of replication.
Plasmids that confer resistance to tetracycline have been
found in a wide range of bacterial species. It has been
suggested that plasmid-mediated tetracycline resistance
(Tetr) in clinical isolates originated from soil organisms
sharing the same habitat as streptomycetes, which synthe-
size the antibiotic (4). In members of the family Enterobac-
teriaceae, plasmid determinants encoding Tetr make up five
separate but related groups, tetA through tetE (20). DNA
sequence analyses indicate that they probably evolved from
a common origin (16, 39). Genes tetA through tetD encode
membrane proteins of similar size (43 kilodaltons [kDa])
which are involved in energy-dependent efflux of tetracy-
cline from the cell (21). In gram-positive streptococci, four
Tetr determinants, tetL, tetM, tetN, and tetO, have been
studied in some detail (3, 10, 20, 21). TetL appears to
mediate Tetr through a membrane efflux, whereas TetM,
TetN, and TetO encode cytoplasmic proteins which presum-
ably protect ribosomes from inhibition by tetracycline. Un-
like the gram-negative Tetr determinants, TetO is a protein
of 72 kDa (3, 6, 19, 35a).
In Bacillus spp., several independent chromosomally me-
diated Tetr determinants have been reported (28). Shishido
et al. (32) showed that protoplasts of a tetracycline-sensitive
(Tets) strain could be regenerated on tetracycline-containing
media. In the presence of exogenous DNA, this process
apparently stimulated excision of an autonomously replicat-
ing Tetr DNA fragment which bore no resemblance to the
exogenous plasmid. The recovered DNA was identical to
pBC16, a Tetr plasmid independently isolated from Bacillus
cereus (1). Wilson and Morgan described endogenous gene
amplifications from regenerated protoplasts associated with
Tetr but without addition of exogenous DNA (41). Williams
and Smith defined the tetB mutation isolated after ethyl
methanesulfonate mutagenesis (40) and postulated that Tetr
was mediated by an alteration in the membrane, since no
difference in ribosomal proteins could be detected by two-
dimensional gel electrophoresis.
In the latter two cases (40, 41), Tetr was genetically
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mapped near the origin of replication. No functional origin
has been isolated from Bacillus subtilis, and the genetic
linkage data between loci in this region is ambiguous because
unknown experimental complications make the data from
reciprocal crosses inconsistent (36, 42). Therefore; physical
characterization ofDNA from the origin region is essential in
understanding the regulation of cellular functions.
We have identified a chromosomal fragment isolated from
the origin region of the B. subtilis chromosome, not capable
of autonomous replication, which mediates Tetr when am-
plified. The amplification phenomenon suggests a need for
increased gene dosage for expression of Tetr. Deletions and
subclones of this DNA were tested for the ability to confer
Tetr in Escherichia coli and B. subtilis. Plasmid pCIS7
encodes a 72-kDa protein, as determined by in vitro tran-
scription-translation analysis. Through hybridization to pre-
viously characterized clones, this DNA was oriented to the
origin-associated loci, which resulted in an accurate physical
map of that chromosomal region.
MATERIALS AND METHODS
Bacterial strains and plasmids. Bacterial strains and plas-
mids used in this study are described in Tables 1 and 2,
respectively.
Media, chemicals, and enzymes. Tryptose blood agar base
(TBAB), tryptic soy broth, and Penassay broth were ob-
tained from Difco Laboratories, (Detroit, Mich.). Luria
broth (LB) is 10 g of tryptone, 5 g of yeast extract, and 10 g
of sodium chloride per liter. Ampicillin, chloramphenicol,
and tetracycline were purchased from Sigma Chemical Co.
(St. Louis, Mo.) and used at concentrations of 50, 5, and 20
,ug/ml, respectively, unless otherwise stated. All other chem-
icals were purchased from Sigma. Restriction enzymes were
obtained from Bethesda Research Laboratories, Inc. (Gaith-
ersburg, Md.), International Biotechnology Inc., and New
England BioLabs, Inc. (Beverly, Mass.). T4 DNA ligase and
E. coli DNA polymerase were purchased from International
Biotechnology Inc. All enzymes were used according to the
instructions of the manufacturer. [o-32P]dCTP was pur-
chased from Dupont, NEN Research Products (Boston,
1801
1802 IVES AND BOTT
TABLE 1. Bacterial strains
Bacterium Relevant genotype Sourceor phenotype
E. coli HB101 recA G. Rapaport
B. subtilis
168 trpC2
Kitl purA cysA trpC2 R. Dedonder (7)
JH858 guaA cysA J. Hoch
KS162 Tn9O7 (Erm) K. Sandman (29)
168(pCIS7) Cat Tet This study
168 Nov Nov Sugino and Bott (36)
168 Nov(pCIS7) Nov Cat Tet This study
RAD1 Tet Wilson and Morgan (41)
Mass.). Translation-grade [35S]methionine was purchased
from ICN Biomedicals, Inc. (Irvine, Calif.). Endonuclease
restriction digests were analyzed by electrophoresis in hor-
izontal 0.7 or 1.0% agarose gels in Tris-acetate buffer (40 mM
Tris [pH 8.0], 20 mM sodium acetate, 2.5 mM EDTA
disodium). InCert agarose was purchased from FMC Corp.,
(Rockland, Maine).
DNA isolation. Small-scale plasmid lysates from E. coli
were prepared according to the method of Holmes and
Quigley (14). Large-scale preparations were done according
to a modified version of the procedure of Norgard (23), using
1% sodium dodecyl sulfate for lysis instead of sodium
deoxycholate and Brij 58, or by the alkaline lysis procedure
outlined in the Promega Biotech GemSeq K/RT sequencing
system technical manual (1986). Plasmids pCIS7 and pCIS2
were excised from the chromosome of B. subtilis KS162,
carrying Tn917, by the method of Youngman et al. (45).
Briefly, integrative plasmid vectors pTV20 and pTV21A2
were linearized with PvuII and transformed into B. subtilis
KS162. Through marker replacement with homologous
Tn917 sequences, chloramphenicol acetyltransferase-resis-
tant (Catr) transformants were obtained. DNA from these
transformants was digested with SphI and religated in dilute
solution. The DNA was transformed into competent E. coli
HB101, and transformants were selected on LB medium
containing ampicillin. By using pTV20 and pTV21A2, DNA
on both sides of the transposon insertion was cloned.
Chromosomal DNA was isolated from Bacillus cells grow-
ing exponentially in Penassay broth according to the method
of Saito and Miura (26) and purified on an equilibrium CsCl
gradient or by the protoplast lysis procedure of Wilson and
Morgan (41). DNA used for contour-clamped homogeneous
electric field (CHEF) electrophoresis was prepared by a
modification of the method of Schwartz and Cantor for DNA
isolation for pulse-field gel electrophoresis (31). An over-
night culture was used to inoculate 25 ml of Penassay broth
to an optical density at 600 nm of approximately 0.1. This
culture was grown at 37°C to an optical density at 600 nm of
0.8; 5 ml was centrifuged at 3,000 x g for 10 min, and the
pellet was suspended in 1 ml of SMMP buffer (4x Penassay
broth, 2x SMM [1 M sucrose, 0.04 M malic acid, 0.04 M
MgCl2]). Lysozyme was added to a final concentration of 2
mg/ml, and the mixture was incubated at 37°C for 30 to 60
min. The extent of protoplasting was examined under a
phase-contrast microscope. A 1-ml amount of 2% InCert
agarose (FMC) was added; 100-,ul portions were quickly
dispensed into a Plexiglas (Rohm & Haas Co., Philadelphia,
Pa.) mold and chilled on ice. The blocks of immobilized
protoplasts were added to lysis buffer (6 M Tris chloride [pH
7.6], 1 M NaCl, 100 mM EDTA [pH 7.5], 0.5% Brij 58, 0.2%
deoxycholate, 0.5% Sarkosyl [CIBA-GEIGY Corp., Sum-
mit, N.J.], 20 ,ug of DNase-free RNase per ml, 1 mg of
lysozyme per ml) and incubated at 37°C for 14 to 18 h with
gentle shaking. The blocks (100-,ul volume) were then trans-
ferred to proteinase K buffer (0.5 M EDTA [pH 9.0], 1%
Sarkosyl, 2 mg of proteinase K per ml), incubated at 50°C for
2 days with gentle shaking, and stored in 10 mM Tris
chloride (pH 7.5)-0.1 mM EDTA (TE) at 4°C.
The blocks containing high-molecular-weight DNA were
suitable as a source of DNA for transformation experiments
(after brief exposure at 42°C to melt the agarose). By using
this DNA, it was possible to demonstrate transformation
linkage to markers not normally linked by using DNA
purified by conventional means (13, 37).
For restriction digestions, one-half block was washed
three times in 10 ml ofTE buffer and then washed twice in 1
ml of 1x restriction buffer at 37°C for 20 min with gentle
shaking. Blocks were placed in 200 ,ug of lx restriction
buffer, 100 U of appropriate enzyme was added, and the
blocks were incubated overnight.
Isolation of plasmid deletions, subclones, and recombinant
bacteriophage. Deletions of pCIS7 (see Fig. 3) were con-
structed as follows. Plasmid DNA (1 ,ug) was partially
digested with HindIII or PstI. Digested DNA was extracted
twice with phenol and once with chloroform, ethanol pre-
cipitated, and suspended in TE buffer. The digested DNA
was religated with T4 DNA ligase and transformed into E.
coli HB101, and transformants were selected on LB medium
containing 50 jig of ampicillin per ml. Plasmid DNA from
these transformants was extracted and screened for dele-
tions by agarose gel electrophoresis. The structures of the
deleted plasmids were analyzed by restriction enzyme map-
ping, using EcoRI, PstI, SphI, and HindlIl single and double
digests.
TABLE 2. Plasmids
Plasmid Selectable Replication" Vector(s) Sourcemarker(s)
pCIS7bTet2 Cat Amp C pTV2O This study
pCIS2 Cat Amp CpTV2CA2 This study
pTV2O Cat Amp Erm C + S Youngman (45)
pTV21A2 Cat Amp Erm C + S Youngman (45)
pMS31 Tet Cat C pJAB1 Sargent and Bennett (30)
pGEM-BLUE Amp C Promega Biotech
pMI1101 Cat Amp C pBR322, pC194 M. Lampe
pAKl Cat Amp C pBR322, pC194 Lampe and Bott (18)
a C, Replication in E. coli; S, replication in B. subtilis.
b Deletions and subclones of pCIS7 are described in the text and the legend to Fig. 3.
Denotes Tetr when pCIS7 is integrated and amplified in the B. suibtilis chromosome.
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FIG. 1. Restriction maps of pCIS7 and pCIS2. Plasmids were constructed as described in the text. Vector DNA is indicated by a box; B.
subtilis DNA is indicated by a bold line. Distances between cleavage sites are indicated in kilobases. Abbreviations: C, chloramphenicol
acetyltransferase from pC194; A, P-lactamase gene of pBR322; Em, erythromycin resistance gene of Tn9O7; Tn, Tn917 DNA; S, SphI; P, PstI;
R, EcoRI.
Subclones of pCIS7 (see Fig. 3) were constructed by
random cldning of restriction enzyme fragments. Plasmid
p6SP is the 6.0-kilobase (kb) SphI-PstI DNA fragment of
pCIS7 constructed by separately digesting 1 ,ug of pCIS7 and
pGEM-BLUE (Promega Biotech) each with PstI. Digests
were phenol extracted, chloroform extracted, ethanol pre-
cipitated, suspended in TE buffer, digested with SphlI, and
treatetl as above. The PstI-SphI-digested plasrhids were
resuspended in TE and iiixtd in 1 x ligase buffer. T4 ligase
was added, and the reattion mixture was incubdted for 2 to
4 h at room temperature. The ligations were then trans-
formed ilnto competent E. coli HB101. Transformants were
screehed on LB medium containing ampicillin, IPTG (iso-
propyl-,-D-thiogalactopyranoside) and X-Gal (5-bromo-4-
chloro-3-indolyl-,3-D-galactopyranoside) (50 ,ug/ml; Sigma).
Potertial subclones (white cologies) were analyzed by aga-
rose gel electrophoresis. Plasmids pY4, pA25, and p4-9 were
constructed in a similar manner, using PstI and partial
HindIII restriction digests. Plasmid pY4 contains the 1.8-kb
PstI fragment, pA25 contains the 1.8-kb HindlIl fragment,
and p4-9 contains three contiguous HindIII fragments of
pCIS7.
A gram-positive selectable marker was cloned into p6SP,
pY4, pA25, and p4-9 for assaying Tetr in B. subtilis. Plasmid
pMIllOl, a vector containing a Catr gene from pC194, was
used (9). Plasmid DNA was digested with BamHI, liberating
the Catr gene cassette; and fragments were randomly cloned
into the unique BamHI site of the pGEM-BLUE subclones.
The recovered clones were screened for ampicillin resis-
tance (Amp) and Catr in E. coli, and their constructions
were confirmed by restriction enzyme mapping.
Recombinant lambda phage F3 was isolated from a
Charon 30 library after screening of plaque lifts by hybrid-
ization to radiolabeled pCIS7 (22). The library was con-
structed by cloning size-fractionated partial Sau3A digests of
B. subtilis DNA into the BamHI site of the lambda vector.
Transformation. Plasmids were introduced into E. coli
strains by the transformation procedure of Hanahan (12). B.
subtilis was made competent by the method of Bott and
Wilson (2).
Hybridization conditions. DNA was transferred from aga-
rose gels to nitrocellulose for Southern blots according to the
method of Smith and Summers (34) and hybridized with
DNA radiolabeled with [x-32P]dCTP by nick translation,
using E. coli DNA polymerase according to the method of
Maniatis et al. (22). For hybridization of DNA separated by
CHEF electrophoresis, agarose gels were similarly treated,
transferred to Zeta-Probe nylon membranes (no. 162-0159);
Bio-Rad Laboratories, Richmond, Calif.), UV cross-linked,
and hybridized as described elsewhere (25).
In vitro transcription and translation. The polypeptides
encoded by pCIS7 deletions and subclones were identified in
an E. coli-derived in vitro transcription-translation system
(8). The radiolabeled polypeptides were separated on 12 and
7.5% polyacrylamide gels containing 0.1% sodium dodecyl
sulfate as described by Laemmli (17). After electrophoresis,
the gels were fixed, treated with Rapid Autoradiography
Enhancer (Dupont, NEN), dried onto filter paper (Whatman,
Inc., Clifton, N.J.), and autoradiographed at -70°C by using
XAR-5 film (Eastman Kodak Co., Rochester, N.Y.). Pres-
tained molecular weight markers from Bethesda Research
Laboratories were used to estimate the sizes of proteins
synthesized.
CHEF electrophoresis. The CHEF apparatus was essen-
tially as described by Chu et al. (5). A 1% agarose gel was
electrophoresed in 0.5x TBE buffer (0.089 M Tris-borate,
0.089 M boric acid) for 40 h at 100 V with an 80-s pulse time.
Saccharomyces cerevisiae chromosomes and concatenated
lambda DNA were used as standards and prepared as
described previously (31, 38).
Assaying Tetr in E. coli. LB broth was inoculated with
HB101, HB101(pCIS7), or HB101(pBR322). In the last two
cases, 50 ,ug of ampicillin per ml was added to maintaih
positive selection for the plasmid. After 3 h of shaking at
37°C, 0.1 ,ug of tetracycline per ml was added to each tube
for induction, and the cultures were shaken for another 1.5 h
at 37°C. The cultures were then diluted and plated on LB
mediumh with 50 pug of ampicillin per ml (for viable cell count)
or on LB medium containing 0.5, 1.0, 2.0, 4.0, 5.0, or 10.0 pLg
of tetracycline per ml.
RESULTS
Isolation of plasmids pCIS7 and pCIS2. A long-term project
in this laboratory is reconstruction of the origin region of the
B. subtilis chromosome through isolation of overlapping
restriction fragments. One approach we have used is to
isolate DNA adjacent to the sites of transposon insertions.
Plasmids pCIS7 and pCIS2 were isolated from Tets B.
subtilis KS162, one of a collection of strains containing
Tn917 insertions in the oriC region (29), according to the
procedure of Youngman et al. (45), using pTV20 and
pTV21A2 integrative vectors. Restriction maps of the plas-
mids prepared by using SphI, PstI, EcoRI, and Hindlll
single and double digests of pCIS7 and pCIS2 are shown in
Fig. 1. Plasmids pCIS7 and pCIS2 contain 11.5 and 2.5 kb,
respectively, of B. subtilis DNA. Subsequent hybridization
to various restriction digests of genomic DNA with pCIS7
and pCIS2 verified that the plasmid DNA obtained from
these rescues accurately represented the chromosome (data
not shown).
Amplification after integration of pCIS7 induces Tetr. To
confirm the chromosomal location of the DNA cloned in
pCIS7, a strain with the plasmid integrated into the chromo-
some [168(pCIS7)] was chosen as a donor for genetic map-
ping. In screening these transformants, an unexpected phe-
notype of Tetr was observed. Although pCIS7 had been
isolated from a transposon insertion in Tets strain KS162,
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transformation of B. subtilis 168 with pCIS7 resulted in
transformants which were Tetr. Although the process is
inefficient, this phenotype could be assayed directly by
plating transformants on TBAB medium containing tetracy-
cline. An increase in the numtber of transformants recovered
could be seen if a subinhibitory (0.3 ,ug/ml) concentration of
tetracycline was added to the transformation sample 30 to 40
min before plating, which suggested that this resistance was
inducible. However, if primary selection was made for the
vector marker (on TBAB medium containing 5 ,ug of chlor-
ampherlicol per ml), many transformants were recovered; all
demonstrated Tetr after 24 to 48 h of incubation at 37°C when
transferred to TBAB containing tetracycline. The Tetr trans-
formants could be induced to high levels of resistance (up to
150 ,g/ml) if sequentially patched to higher levels of tetra-
cycline. Ability to survive high levels of tetracycline was
rapidly lost if cells were switched from tetracycline-con-
taining medium to medium containing chloramphenicol.
The Tetr transformants were not cross-resistant to mi-
notetracycline, erythromycin, kanamycin, or tunicamycin
but were resistant to the related tetracycline analog chlortet-
racycline, which suggested that the resistance was not a
general transport defect. We were also able to determine, by
the method of Speer and Salyers (35), that tetracycline was
not inactivated by these resistant strains (C. L. Ives and
K. F. Bott, unpublished results).
Since previously reported Tetr determinants isolated from
gram-positive organisms, including B. subtilis, are also func-
tional in E. coli (11), pCIS7 was tested for Tetr in E. coli.
Under the experimental conditions described in Materials
and Methods, pCIS7 did not express Tetr in E. coli.
In EcoRI digests of chromosomal DNA prepared from B.
subtilis 168(pCIS7) transformants, amplified restriction frag-
ments of 12 and 6.5 kb were visualized in agarose gels (Fig.
2). Hybridization of these chromosomal digests with pCIS7
showed that the amplified 12- and 6.5-kb EcoRI fragments
corresponded to the integrated plasmid (Fig. 2B, lanes 4
through 16). B. subtilis 168 contained an 11.5-kb EcoRI
fragment which hybridized to pCIS7 (Fig. 2B, lane 2).
RAD1, a Tetr strain derived from protoplasts (41), contained
an amplified 11.5-kb EcoRI fragment which also hybridized
to pCIS7 (Fig. 2B, lane 3). Chromosomal DNA prepared
from Tetr transformants was always accompained by ampli-
fied sequences, but primary selection for Catr transformants
did not show this amplification (data not shown), which
suggested that a substantial increase in copy number of the
integrated sequences is necessary for Tetr. Furthermore,
maintaining the isolates on higher levels of chloramphenicol
did not maintain the amplification. Removal of the tetracy-
cline selection (regardless of chloramphenicol resistance
[Cmr] association) permitted loss of amplification.
Expression of Tetr in B. subtilis requires amplification of
DNA. The deletions and subclones constructed for in vitro
transcription-translation analysis were tested for the ability
to confer Tetr when transformed into B. subtilis 168 (Fig. 3,
column 1). Primary selection on TBAB medium containing
chloramphenicol was used to monitor transformants; tl¶ese
transformants were subsequently screened for the ability to
confer Tetr if transferred to successively higher levels of
tetracycline. Those deletions that conferred Tetr (pG1, pG9,
pRll, pY2, and pG4) all contained a 1.8-kb Hindlll fragment
consisting of 1.3 kb of Tn917 DNA and 800 base pairs of B.
subtilis DNA.
In EcoRI restriction digests of chromosomal DNA pre-
pared from 168(pG9), 168(pR11), 168(pY2), and 168(pG4), a
12-kb and a 6.5-kb fragment were amplified (data not
shown). This is the same amplification pattern seen with
168(pCIS7) (Fig. 2, lanes 4 through 16). A proposed model
for the integration and amplification of pCIS7 and deletions
is shown in Fig. 4. The size of these EcoRI restriction
enzyme fragments is predicted by our integration model.
With this model, we would also predict an amplification of a
19-kb Sfil restriction enzyme fragment and an increase in
size of a 60-kb BamHI fragment, which was demonstrated in
other experiments (data not shown). Janniere et al. de-
scribed the construction of stable gene amplifications in the
B. subtilis chromosome (15). For amplification to occur, a
genetic marker has to be flanked by a directly repeated
sequence. A single crossover event would produce a dupli-
cation of chromosomal sequences on either side of the target
DNA. In our case, the deleted plasmids which conferred Tetr
contained a directly repeated 1.8-kb HindIII fragment when
integrated into the chromosome. The duplicated sequences
could then be used for recombination and amplification of
the entire 12.0-kb EcoRI restriction fragment during subse-
quent replication and recombination events. Plasmids pG6
and pR13 lack DNA flanking the 72 kDa gene which is
essential for generating the same type of direct repeat. We
believe that this is the reason they do not confer Tetr.
The 1.8-kb HindIII fragment and three other fragments of
pICS7 were subcloned and tested for the ability to confer
Tetr when integrated into the B. subtilis chromosome (Fig. 3,
column 1). None of the four subclones constructed (pA25,
p4-9, pY4, and p6SP) conferred Tetr on B. subtilis, which
indicated that the DNA was not sufficient to encode the
72-kDa protein or to confer amplification properties. Plas-
mids pG6 and pR13 lack DNA flanking the 72-kDa gene
which is thought to be necessary for generating the same
type of direct repeat. These two plasmids, when integrated
into the B. subtilis chromosome, gave Cmr transformants but
could not confer Tetr. Synthesis of the 72-kDa gene and
amplification of this DNA in B. subtilis appears necessary
for expression of Tetr.
Expression of a protein associated with Tetr in vitro. The
protein products encoded by deletions and subclones of
pCIS7 were examined (Fig. 3). Preliminary experiments with
isolated membrane fractions of 168(pCIS7) provided a com-
plex though reproducible protein-staining profile in which a
72-kDa protein was present. An analogous band was not
detected in wild-type B. subtilis 168 or other Tets derivatives
(Ives and Bott, unpublished results). The deletion plasmids
pGl, pG4, pG6, pRll, pR13, and pY2 and subclones p4-9,
p6SP, and pY4, along with positive control pCIS7 and
negative controls pTV20 and pGEM-BLUE, were purified
on a CsCl gradient and introduced ihto a coupled E. coli
transcription-translation system (8). Protein products, radio-
labeled with [35S]methionine, were separated on sodium
dodecyl sulfate-polyacrylamide gels (Fig. 5). In addition to
producing the intact 31-kDa P-lactamase protein and other
smaller bands, pCIS7 and pY2 each produced a 72-kDa band
which was absent from the other plasmids (Fig. 3, column 2).
Plasmids pRll and p4-9 each produced a truncated version
of this protein of approximately 68 kDa. Plasmid pRll also
produced a protein of 64 kDa. Plasmids pGl and pG4
produced smaller proteins of 20 and 24 kDa, respectively.
The negative controls, pTV20 and pGEM-BLUE, did not
synthesize any protein larger than that expressed by the
,-lactamase gene, nor did pR13 or pG6. Collectively, the
results suggest that a 72-kDa protein is associated with the
region of the genome that confers the Tetr phenotype. The
promoter of the 72-kDa gene appeared to lie within the
cloned sequences, since both pRll and p4-9 synthesized a
J. BACTERIOL.
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FIG. 2. Transformation of the Tetr phenotype. (A) Agarose gel electrophoresis of EcoRI digests of chromosomal DNA (3 F±g/ml) prepared
from four separate Cmr isolates after transformation with pCIS7 and of control strains 168 and RAD1. Lanes: 1 and 16, size marker 1-kb
ladder; 2, strain 168; 3, RAD1, a protoplasted Tetr regenerant; 4, 7, 10, and 13, separate Cmr transformants (selected at 5 pg of
chloramphenicol per ml); 5, 8, 11, and 14, the original transformants from lanes 4, 7, 10, and 13 after passage to chloramphenicol (20 ,ug/ml);
6, 9, 12, and 15, transformants from lanes 5, 8, 11, and 14 after passage to tetracycline (20 ,ug/ml); 17, vector alone; 19, pCIS7 (see Table 1).
Marker dots between lanes 9 and 10 designate 12 and 6.5 kb. (B) Southern blot hybridization of agarose gel from panel A probed with











































FIG. 3. Deletions and subclones of pCIS7: Tetr in B. subtilis and proteins synthesized in vitro. Deletions and subclones were constructed
as described in the text. Lines indicate DNA remaining in deletions and subclones. Column 1: Percentage of Catr transformants able to grow
on media containing 50 F.g of tetracycline per ml. Catr transformants were patched to tetracycline-containing media at sequentially higher
concentrations (10, 15, 20, and 50). Column 2: Sizes (in kilodaltons) of proteins synthesized in an E. coli in vitro transcription-translation
system. Abbreviations: NT, no transformants; ND, not done; --, no proteins synthesized; R, EcoRI; S, Sphl; H, HindlIl; P, PstI.
truncated 68-kDa protein but were in different vector back-
grounds. These results suggest that the 3.1-kb PstI-EcoRI
fragment of pCIS7 is essential for the expression of a protein
associated with Tetr.
Genetic and physical localization of pCIS7. As mentioned at
the outset, our original aim was to isolate B. subtilis chro-
mosomal fragments encompassing the origin of replication.
We thus wished to map the DNA carried by pCIS7. The
initial transposon insertion from which pCIS7 was excised
was 42% linked to guaA by transduction (29). However, our
preliminary transduction analysis, using B. subtilis
168(pCIS7) as a donor, indicated that pCIS7 was more
closely associated with the purA locus. Strain 168(pCIS7)
demonstrated 7% linkage to the purA locus by transforma-
tion using high-molecular-weight DNA prepared by a modi-
fication of the method of Schwartz and Cantor (31) (data not
shown). No linkage was seen with DNA prepared by con-
ventional means.
Since accurate genetic mapping in this region of the
chromosome is difficult (36, 42), localizing pCIS7 by physical
linkage with other characterized clones of DNA would
substantiate the proposed order of the genetic markers and
eliminate the need for three-factor crosses, which at best
give ambiguous results in this region of the chromosome. To
this end, we used pCIS7 as a probe against a lambda Charon
30 library and isolated a recombinant phage, F3. Through
hybridization analysis, phage F3 was shown to partially
overlap pMS31, a subclone of phage 529 characterized by
Sargent and Bennett (30). Phage 529 maps near purA and
binds the membrane. Membrane-binding studies using inde-
pendently isolated DNA from this region have recently
confirmed the linear restriction map of these clones (N.
Sueoka, personal communication).
Using CHEF electrophoresis (5), we have been able to
determine the orientation of this cluster of cloned DNA to
other origin markers. Plasmid pCIS7 contains an-Sfil restric-
tion site within the 6.0-kb SphI-PstI restriction fragment and
hybridizes to a 250-kb and a 150-kb Sfil restriction fragment
in an Sfil chromosomal digest of B. subtilis 168; it also
hybridizes to a 200-kb NotI restriction fragment. Plasmid
pAK1, a clone containing the gyrA and gyrB genes (16),
hybridizes to a single 250-kb Sfil restriction fragment and a
200-kb NotI fragment, whereas pMS31 hybridizes to a
150-kb SfiI restriction fragment and a 200-kb NotI fragment.
A physical map of this region of the chromosome con-
structed through overlapping clones is shown in Fig. 6.
These results strongly indicate that the order of markers in
the chromosome is purA-pMS31-pCIS7-pCIS2-pAK1(Nov)-
guaA and expand the physical characterization of the chro-
mosome in this region.
DISCUSSION
Isolation of pCIS7 by excision of DNA adjacent to Tn917
insertions has led to a more complete characterization of the
origin region of B. subtilis. We have now linked four clones
comprising 30 kb of contiguous DNA from this region.
Through CHEF electrophoresis, these clones have been
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FIG. 4. Proposed model of integration and amplification of pCIS7 into the B. subtilis chromosome. (A) pCIS7 integrating into the B.
subtilis chromosome by a single crossover event; (B) outcome of such an integration, with duplicated chromosomal DNA flanking vector
sequences; (C) amplification of the duplicated sequences in panel B by crossover between nascent daughter chromosomes. The expected
amplified EcoRI restriction fragments are given. Open boxes indicate vector sequences. Black boxes show cloned chromosomal sequences.
Thin lines flanking the black boxes depict chromosomal DNA adjacent to the cloned fragment. Abbreviations: R, EcoRI; S, SphI; F, SfiI.
placed on a single NotI restriction fragment and two Sfil
fragments encompassing 400 kb of DNA, providing an
accurate physical map of the origin region where many
genetic anomalies have been described. 3 4 12
Amplification of a component within pCIS7 was required 1 3 4 6
for expression of Tetr. This was demonstrated by deletion
analysis, in which those plasmids which conferred Tetruponf
transformation and integration into the chromosome con- 97
tained DNA which gave rise to a direct repeat flanking the
72-kDa gene. The deletion plasmids themselves did not need
to contain the 72-kDa gene, because this DNA was regener- 68 *
ated from the single intact copy already present in the
chromosome, provided that a direct repeat flanking the gene
was present. Theoretically, this flanking DNA (the 1.8-kb
HindlIl fragment) served as a bridge between replicating 103P
sister chromatids during DNA replication, regenerating the
complete 12-kb EcoRI fragment seen in chromosomal di-
gests of these integrated strains. An alteration in the 6.5-kb 43
EcoRI fragment was seen in pGl, but this was due to
deletion of vector DNA. The 12-kb EcoRI fragment was still
regenerated and amplified.
The numer of copies necessary to confer Tetr is not known
but is almost certainly more than 20 per chromosome. Young 29-
has shown that plasmid DNA integrated into the B. subtilis
chromosome can be amplified 15-fold when selection is
increased from 5 to 20 ,ug of chloramphenicol per ml (44). In FIG. 5. In vitro transcription-translation analysis of pCIS7 dele-
our case, this amount of amplification did not significantly tions and subclones. In vitro transcription-translation products
alter the intensity of restriction fragments in a chromosomal derived from pGEM-BLUE, p6SP, pY4, p4-9, pCIS7, pRll, pY2,
digest (Fig. 2B). Transfer of 168(pCIS7) from 20 ,ug of pG4, pGl, pG6, pR13, and pTV20 (lanes 1 through 12). Molecular
chloramphenicol per ml to tetracycline resulted in a dramatic size markers on the left are expressed in kilodaltons.
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FIG. 6. Restriction map of the purA region of the B. subtilis chromosome. Cloned chromosomal DNA (hatched line) showing orientation
to purA, pAK1, and guaA, with clones indicated underneath. Double lines on phage F3 indicate uncertainty of endpoints of cloned DNA. The
EcoRI fragment believed to be required for Tetr is indicated at the top (see text for details). Numbers above arrows indicate sizes of Sfi1
fragments in the chromosome. Plasmids pCIS7 and pCIS2 were cloned from the Tn917 insertion.
increase in intensity of EcoRI fragments in a chromosomal
digest, which indicated that more than 15 copies of inte-
grated plasmid was needed for Tetr. When 168(pCIS7) was
passaged from TBAB containing tetracycline back to TBAB
containing 20 ,ug of chloramphenicol per ml, this intense
banding was lost (Ives and Bott, unpublished observations).
Although the four chromosomal Tetr determinants re-
ported in B. subtilis share some properties, there are differ-
ences. The tetB determinant characterized by Williams and
Smith (40) is reported to map between the guaA and cysA
loci on the B. subtilis chromosome, whereas the B. subtilis
DNA in pCIS7 is clearly located near the purA locus.
However, since the genetic mapping data are notoriously
inconsistent in this region, we cannot rule out the possibility
that the tetB locus was imprecisely mapped, just as the
Tn9J7 insertion in B. subtilis KS162 was initially. We have
been unable to detect amplified DNA in the tetB strain (Ives
and Bott, unpublished results). It is unclear whether resis-
tance is determined by overproduction of a normal gene, as
postulated for 168(pCIS7). The phenotype of this nonampli-
fied strain could be ascribed to a promoter mutation which
would cause an increase in transcription in this DNA,
essentially mimicking the effect of an increase in gene
dosage. However, experimental evidence to support this
hypothesis is currently lacking.
The Tetr determinant characterized by Shishido et al. (33)
(pNS1981) also differs from the Tetr determinant reported
here. Unfortunately, there is no genetic mapping data con-
cerning the location of the Tetr determinant of pNS1981, so
it is not known whether it arose from the origin region.
Sakaguchi and Shishido have recently reported the sequence
homology between fragments from the chromosome of sev-
eral B. subtilis isolates which confer Tetr when cloned on a
multicopy plasmid vector (27, 28). Although these plasmids
were Tetr in E. coli (in a range of 30 to 80 ,ug/ml), we were
unable to show Tetr of pCIS7 in E. coli by using similar
procedures. However, it must be noted that our experiments
were all conducted under the assumption that the pBR322
replicon bearing these test fragments would have been
capable of sufficient amplification to elicit Tetr if it could be
produced. We did not quantitate the copy number of the
vector and our test plasmids but assumed that it would be
different from the copy number of the normal pBR322
replicon. Plasmid pNS1981 is nearly identical to pBC16 (32);
hybridization analysis using pBC16 as a probe demonstrated
homology between this plasmid and pCIS7 only at low
stringency (Ives and Bott, unpublished observations). The
Tetr gene of pBC16 has been sequenced and is estimated to
encode a protein of 50 kDa (33), whereas in vitro transcrip-
tion-translation data suggest that the Tetr determinant of
pCIS7 is 72 kDa. Another gram-positive Tetr determinant,
tetO, was recently sequenced by LeBlanc et al. (19) and
encodes a 72-kDa protein. Preliminary sequence analysis
between tetO and DNA fragments of pCIS7 have not dem-
onstrated any sequence homology (Ives and Bott, unpub-
lished results).
The endogenous gene amplifications associated with Tetr
described by Wilson and Morgan (41) do appear to involve
the same DNA as do Tetr 168(pCIS7) transformants, since
pCIS7 hybridizes to an 11.5-kb EcoRI chromosomal frag-
ment in these strains. However, DNA from these proto-
plasted strains has not been cloned or physically character-
ized. Since restriction enzyme digest patterns, function in E.
coli, cross-hybridization with other Bacillus-derived Tetr
determinants, and predicted size of protein associated with
the Tetr phenotype (28, 32) all differ considerably, there may
be multiple chromosomal fragments capable of eliciting this
phenotype.
Collectively, these results suggest that more than one
locus on the B. subtilis chromosome can be altered to confer
Tetr or that analogous regions on the chromosome of various
B. subtilis strains confer Tetr differently.
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